- Report
- September 2026
- 185 Pages
Global
From €3261EUR$3,545USD£2,778GBP
€3623EUR$3,939USD£3,087GBP
- Report
- September 2026
- 195 Pages
Global
From €3261EUR$3,545USD£2,778GBP
€3623EUR$3,939USD£3,087GBP
- Report
- September 2026
- 181 Pages
Global
From €3261EUR$3,545USD£2,778GBP
€3623EUR$3,939USD£3,087GBP
- Clinical Trials
- April 2025
- 50 Pages
Global
From €1380EUR$1,500USD£1,175GBP
- Report
- August 2025
- 150 Pages
Global
From €4461EUR$4,850USD£3,801GBP
- Report
- January 2024
- 87 Pages
Global
From €3500EUR$4,076USD£3,086GBP
From €2391EUR$2,600USD£2,037GBP
- Report
- October 2024
- 92 Pages
Global
From €3500EUR$4,076USD£3,086GBP
- Report
- October 2026
- 50 Pages
Global
From €2437EUR$2,650USD£2,077GBP
Acetylcysteine is a medication used to treat respiratory conditions such as bronchitis, bronchiolitis, and pneumonia. It is also used to treat chronic obstructive pulmonary disease (COPD) and cystic fibrosis. Acetylcysteine works by thinning mucus and making it easier to cough up. It is available in both oral and intravenous forms.
Acetylcysteine is a widely used medication in the respiratory drugs market. It is used to treat a variety of conditions, from acute bronchitis to chronic obstructive pulmonary disease. It is also used to treat cystic fibrosis, a genetic disorder that affects the lungs. Acetylcysteine is generally well tolerated and has few side effects.
Some companies in the Acetylcysteine market include GlaxoSmithKline, Merck, Pfizer, and Sanofi. These companies produce and market a variety of respiratory drugs, including Acetylcysteine. Show Less Read more